Han Yan (Yu Hu)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 70

Top Venues

American journal of hematology

Leukemia

Annals of medicine

Blood cancer journal

Huazhong University of Science and Technology Tongji Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Huazhong University of Science and Technology Tongji Medical College Jul 01 1982

China

PHD :: Institute of Hematology

Publications

Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Jiasi Zhang, Yuxi Liu, Liping Zuo, Fengjuan Fan, Han Yan, Fei Zhao, Junying Li, Chi Ma, Qun Li, Aoshuang Xu, Jian Xu, Bo Zhang, Han Yan, Chunyan Sun
Class Ⅱ ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma. Blood advances (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Ruiqi Zhu, Courtney M Shirley, S Haihua Chu, Li Li, Bao H Nguyen, Jaesung Seo, Min Wu, Tessa Seale, Amy S Duffield, Louis M Staudt, Mark J Levis, Han Yan, Donald Small
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition. Leukemia 38 (7) (2024)
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology (2024)
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Ruiqi Zhu, Courtney M Shirley, S Haihua Chu, Li Li, Bao H Nguyen, Jaesung Seo, Min Wu, Tessa Seale, Amy S Duffield, Louis M Staudt, Mark J Levis, Han Yan, Donald Small
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition. Leukemia 38 (7) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Min Xu, Jiachen Liu, Linlin Huang, Jinhui Shu, Qiuzhe Wei, Han Yan, Heng Mei
A novel scoring model for predicting efficacy and guiding individualised treatment in immune thrombocytopaenia. British journal of haematology (2024)
Ruiqi Zhu, Courtney M Shirley, S Haihua Chu, Li Li, Bao H Nguyen, Jaesung Seo, Min Wu, Tessa Seale, Amy S Duffield, Louis M Staudt, Mark J Levis, Han Yan, Donald Small
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition. Leukemia (2024)
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Han Yan, Chunyan Sun
Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis. Annals of medicine 56 (1) (2024)
Ruiqi Zhu, Courtney M Shirley, S Haihua Chu, Li Li, Bao H Nguyen, Jaesung Seo, Min Wu, Tessa Seale, Amy S Duffield, Louis M Staudt, Mark J Levis, Han Yan, Donald Small
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition. Leukemia 38 (7) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Yinqiang Zhang, Chenggong Li, Mengyi Du, Huiwen Jiang, Wenjing Luo, Lu Tang, Yun Kang, Jia Xu, Zhuolin Wu, Xindi Wang, Zhongpei Huang, Yanlei Zhang, Di Wu, Alex H Chang, Han Yan, Heng Mei
Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood cancer journal 13 (1) (2023)
Lu Tang, Zhongpei Huang, Heng Mei, Han Yan
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects. Signal transduction and targeted therapy 8 (1) (2023)
Yinqiang Zhang, Chenggong Li, Mengyi Du, Huiwen Jiang, Wenjing Luo, Lu Tang, Yun Kang, Jia Xu, Zhuolin Wu, Xindi Wang, Zhongpei Huang, Yanlei Zhang, Di Wu, Alex H Chang, Han Yan, Heng Mei
Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood cancer journal 13 (1) (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Han Yan, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zunmin Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Renbin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study. Blood advances (2023)
Yinqiang Zhang, Chenggong Li, Mengyi Du, Huiwen Jiang, Wenjing Luo, Lu Tang, Yun Kang, Jia Xu, Zhuolin Wu, Xindi Wang, Zhongpei Huang, Yanlei Zhang, Di Wu, Alex H Chang, Han Yan, Heng Mei
Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood cancer journal 13 (1) (2023)
Qun Li, Bo Zhang, Qianwen Cheng, Fei Zhao, Junying Li, Han Yan, Aoshuang Xu, Chunyan Sun, Han Yan
Hematologists' awareness of venous thromboembolism in multiple myeloma: a national survey in China. Annals of medicine 55 (2) (2023)
Lijuan Deng, Zhi-Ming Li, Huilai Zhang, Haiwen Huang, Jian-da Hu, Lihong Liu, Ting Liu, Jie Jin, Zunmin Zhu, Wenyu Li, Zhenqian Huang, Wenrong Huang, Ke-Shu Zhou, Haiyan Yang, Mingzhi Zhang, Kaiyang Ding, Hui Zhou, Han Yan, Yuerong Shuang, Junning Cao, Sujun Gao, Dengju Li, Zimin Sun, Qingyuan Zhang, Shuhua Yi, Chun-Yan Ji, Liansheng Zhang, Cheng Hou, Yue Du, Weige Wang, Renbin Zhao, Yuqin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study. American journal of hematology (2023)
Yinqiang Zhang, Chenggong Li, Mengyi Du, Huiwen Jiang, Wenjing Luo, Lu Tang, Yun Kang, Jia Xu, Zhuolin Wu, Xindi Wang, Zhongpei Huang, Yanlei Zhang, Di Wu, Alex H Chang, Han Yan, Heng Mei
Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood cancer journal 13 (1) (2023)
Chenggong Li, Jia Xu, Wenjing Luo, Danying Liao, Wei Xie, Qiuzhe Wei, Yinqiang Zhang, Xindi Wang, Zhuolin Wu, Yun Kang, Jin'e Zheng, Wei Xiong, Jun Deng, Han Yan, Heng Mei
Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma. Leukemia (2023)
Yinqiang Zhang, Chenggong Li, Mengyi Du, Huiwen Jiang, Wenjing Luo, Lu Tang, Yun Kang, Jia Xu, Zhuolin Wu, Xindi Wang, Zhongpei Huang, Yanlei Zhang, Di Wu, Alex H Chang, Han Yan, Heng Mei
Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood cancer journal 13 (1) (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Yinqiang Zhang, Chenggong Li, Mengyi Du, Huiwen Jiang, Wenjing Luo, Lu Tang, Yun Kang, Jia Xu, Zhuolin Wu, Xindi Wang, Zhongpei Huang, Yanlei Zhang, Di Wu, Alex H Chang, Han Yan, Heng Mei
Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood cancer journal 13 (1) (2023)
Chenggong Li, Jiachen Liu, Jun Deng, Jia Xu, Yun Kang, Wenjing Luo, Lei Chen, Han Yan, Heng Mei
Multiple immunoglobulin isotype switch after bispecific CAR-T cell therapy in multiple myeloma-A case report. British journal of haematology (2022)
Liang V Tang, Yanyi Tao, Yuanzheng Feng, Jiewen Ma, Wenyi Lin, Yuyang Zhang, Yi Zhang, Tingting Wu, Yaohua Cai, Hui Lu, Jun Wei, Javier Corral, Han Yan
Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice. Science translational medicine 14 (673) (2022)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Wenjuan Yu, Jie Jin
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial. American journal of hematology 97 (12) (2022)
Chunyan Sun, Jian Xu, Bo Zhang, Haifan Huang, Lei Chen, Han Yan, Aoshuang Xu, Fei Zhao, Daijuan Huang, Liqiong Liu, Jian Li, Yu Hu
Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome. Blood advances 5 (12) (2021)
Danying Liao, Jesse Sundlov, Jieqing Zhu, Heng Mei, Han Yan, Debra K Newman, Peter J Newman
Atomic Level Dissection of the Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) Homophilic Binding Interface: Implications for Endothelial Cell Barrier Function. Arteriosclerosis, thrombosis, and vascular biology 42 (2) (2021)
Heng Mei, Xiaofan Liu, Yan Li, Hu Zhou, Ying Feng, Guangxun Gao, Peng Cheng, Ruibin Huang, Linhua Yang, Jianda Hu, Ming Hou, Yazhou Yao, Li Liu, Yi Wang, Depei Wu, Liansheng Zhang, Changcheng Zheng, Xuliang Shen, Qi Hu, Jing Liu, Jie Jin, Jianmin Luo, Yun Zeng, Sujun Gao, Xiaohui Zhang, Xin Zhou, Qingzhi Shi, Ruixiang Xia, Xiaobao Xie, Zhongxing Jiang, Li Gao, Yuansong Bai, Yan Li, Junye Xiong, Runzi Li, Jianjun Zou, Ting Niu, Renchi Yang, Han Yan
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. Journal of hematology & oncology 14 (1) (2021)
Yukai Jing, Li Luo, Ying Chen, Lisa S Westerberg, Peng Zhou, Zhiping Xu, Andrés A Herrada, Chan-Sik Park, Masato Kubo, Heng Mei, Han Yan, Pamela Pui-Wah Lee, Bing Zheng, Zhiwei Sui, Wei Xiao, Quan Gong, Zhongxin Lu, Chaohong Liu
SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal transduction and targeted therapy 6 (1) (2021)
Rong Tao, Lei Fan, Yongping Song, Han Yan, Wei Zhang, Yafei Wang, Wei Xu, Jianyong Li
Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4). Signal transduction and targeted therapy 6 (1) (2021)
Qian Lei, Fei Gao, Teng Liu, Wenxiang Ren, Li Chen, Yulin Cao, Wenlan Chen, Shaojun Guo, Qiong Zhang, Weiqun Chen, Hongxiang Wang, Zhichao Chen, Qiubai Li, Han Yan, An-Yuan Guo
Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow-derived mesenchymal stem cells and slow age-related degeneration. Science translational medicine 13 (578) (2021)
Heng Mei, Min Xu, Guolin Yuan, Feiyue Zhu, Jingming Guo, Ruibin Huang, Jun Qin, Tingting Lv, Fangmei Qin, Huili Cai, Ping Yin, Tingting Qin, Han Yan
A multicentre double-blind, double-dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients. British journal of haematology 195 (5) (2021)
Lu Tang, Yinqiang Zhang, Han Yan, Heng Mei
T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies. BioMed research international 2021 (2021)
Moran Wang, Shengling Ma, Wei Shi, Yuanyuan Zhang, Shanshan Luo, Han Yan
Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study. Cancer medicine 10 (10) (2021)
Weiqi Yao, Hongyun Gong, Heng Mei, Lei Shi, Jin-Ming Yu, Han Yan
Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme. Journal of oncology 2021 (2021)
Ze Lin, Bobin Mi, Xuehan Liu, Adriana C Panayi, Yuan Xiong, Hang Xue, Wu Zhou, Faqi Cao, Jing Liu, Liangcong Hu, Yiqiang Hu, Lang Chen, Chenchen Yan, Xudong Xie, Junfei Guo, Zhiyong Hou, Yun Sun, Ying-Ze Zhang, Han Yan, Guohui Liu
Nomogram for Predicting Deep Venous Thrombosis in Lower Extremity Fractures. BioMed research international 2021 (2021)
Fengjuan Fan, Stefano Malvestiti, Sonia Vallet, Judith Lind, Jose Manuel Garcia-Manteiga, Eugenio Morelli, Qinyue Jiang, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Andreas Stadlbauer, Chunyan Sun, Heng Mei, Martin Pecherstorfer, Latifa Bakiri, Erwin F Wagner, Giovanni Tonon, Martin Sattler, Han Yan, Pierfrancesco Tassone, Dirk Jaeger, Klaus Podar
JunB is a key regulator of multiple myeloma bone marrow angiogenesis. Leukemia 35 (12) (2021)
Ruiqi Zhu, Li Li, Bao Nguyen, Jaesung Seo, Min Wu, Tessa Seale, Mark Levis, Amy Duffield, Han Yan, Donald Small
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation. Signal transduction and targeted therapy 6 (1) (2021)
Heng Mei, Xiaofan Liu, Yan Li, Hu Zhou, Ying Feng, Guangxun Gao, Peng Cheng, Ruibin Huang, Linhua Yang, Jianda Hu, Ming Hou, Yazhou Yao, Li Liu, Yi Wang, Depei Wu, Liansheng Zhang, Changcheng Zheng, Xuliang Shen, Qi Hu, Jing Liu, Jie Jin, Jianmin Luo, Yun Zeng, Sujun Gao, Xiao-Hui Zhang, Xin Zhou, Qingzhi Shi, Ruixiang Xia, Xiaobao Xie, Zhongxing Jiang, Li Gao, Yuansong Bai, Yan Li, Junye Xiong, Runzi Li, Jianjun Zou, Ting Niu, Renchi Yang, Han Yan
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: results from an open-label extension study. Journal of thrombosis and haemostasis : JTH (2021)
Yaogong Wu, Wenlan Chen, Wenjing Li, Miaomiao Zhao, Qiuzhe Wei, Xiaoping Zhang, Heng Mei, Yadan Wang, Han Yan
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies. Leukemia & lymphoma 61 (14) (2020)
Fei Peng, You Qin, Shidai Mu, Jingwen Li, Lisha Ai, Han Yan
Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis. Journal of cancer research and clinical oncology 146 (12) (2020)
Lei Chen, Jianming Yu, Wenjuan He, Li Chen, Guolin Yuan, Fang Dong, Wenlan Chen, Yulin Cao, Jingyan Yang, Liling Cai, Di Wu, Qijie Ran, Lei Li, Qiaomei Liu, Wenxiang Ren, Fei Gao, Hongxiang Wang, Zhichao Chen, Robert Peter Gale, Qiubai Li, Han Yan
Risk factors for death in 1859 subjects with COVID-19. Leukemia 34 (8) (2020)
Jun Deng, Dan Li, Heng Mei, Liang Tang, Hua-Fang Wang, Han Yan
Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency. BMC medical genetics 21 (1) (2020)
Yuying Liu, Yiliang Fang, Xinfeng Chen, Zhenfeng Wang, Xiao-Yu Liang, Tianzhen Zhang, Mengyu Liu, Nannan Zhou, Jiadi Lv, Ke Tang, Jing Xie, Yunfeng Gao, Feiran Cheng, Yabo Zhou, Zhen Zhang, Han Yan, Xiao-Hui Zhang, Quan-Li Gao, Yi Zhang, Bo Huang
Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Science immunology 5 (43) (2020)
Qiubai Li, Lei Chen, Qin Li, Wenjuan He, Jianming Yu, Li Chen, Yulin Cao, Wenlan Chen, null Di Wu, Fang Dong, Liling Cai, Qijie Ran, Lei Li, Qiaomei Liu, Wenxiang Ren, Fei Gao, Hongxiang Wang, Zhichao Chen, Robert Peter Gale, Han Yan
Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission. Leukemia 34 (9) (2020)
Heng Mei, Lili Luo, Han Yan
Thrombocytopenia and thrombosis in hospitalized patients with COVID-19. Journal of hematology & oncology 13 (1) (2020)
Qiubai Li, Yulin Cao, Lei Chen, Di Wu, Jianming Yu, Hongxiang Wang, Wenjuan He, Li Chen, Fang Dong, Weiqun Chen, Wenlan Chen, Lei Li, Qijie Ran, Qiaomei Liu, Wenxiang Ren, Fei Gao, Zhichao Chen, Robert Peter Gale, Han Yan
Hematological features of persons with COVID-19. Leukemia 34 (8) (2020)
Lei Chen, Fengjuan Fan, Jun Deng, Jian Xu, Aoshuang Xu, Chunyan Sun, Han Yan
Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era. Annals of hematology 98 (4) (2019)
Han Yan, Ziying Li, Wei Shi, Yanxue Yin, Heng Mei, Huafang Wang, Tao Guo, Jun Deng, Han Yan, Xuan Lu
Early diagnosis of cerebral thrombosis by EGFP-EGF1 protein conjugated ferroferric oxide magnetic nanoparticles. Journal of biomaterials applications 33 (9) (2019)
Xuejiao Yin, Sui Huang, Aoshuang Xu, Fengjuan Fan, Lei Chen, Chunyan Sun, Han Yan
Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q). Journal of cellular biochemistry 121 (2) (2019)
Jun Deng, Dan Li, Heng Mei, Liang Tang, Hua-Fang Wang, Han Yan
Combined deficiency of factors V and VIII in a Chinese family due to a novel nonsense mutation in lectin mannose binding protein 1. International journal of laboratory hematology 42 (1) (2019)
Huiwen Jiang, Chenggong Li, Ping Yin, Tao Guo, Lin Liu, Linghui Xia, Yaohui Wu, Fen Zhou, Lisha Ai, Wei Shi, Xuan Lu, Huafang Wang, Lu Tang, Qiuzhe Wei, Jun Deng, Runming Jin, Wei Xiong, Jian Dong, Heng Mei, Han Yan
Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trial. American journal of hematology 94 (10) (2019)
Shidai Mu, Lisha Ai, Fengjuan Fan, You Qin, Chunyan Sun, Han Yan
Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis. Cancer cell international 18 (2018)
Ruiqi Zhu, Wenyi Lin, Weiwei Zhao, Fengjuan Fan, Liang Tang, Han Yan
A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia. Journal of cellular biochemistry 120 (3) (2018)
Xuejiao Yin, Sui Huang, Ruiqi Zhu, Fengjuan Fan, Chunyan Sun, Han Yan
Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia. Cancer cell international 18 (2018)
Shidai Mu, Lisha Ai, Fengjuan Fan, Chunyan Sun, Han Yan
Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis. Cancer cell international 18 (2018)
Xiao-Jun Huang, Lugui Qiu, Jie Jin, Daobin Zhou, Xiequn Chen, Ming Hou, Jianda Hu, Han Yan, Xiaoyan Ke, Junmin Li, Yingmin Liang, Ting Liu, Yue Lv, Hanyun Ren, Aining Sun, Jianmin Wang, Chunting Zhao, Mariya Salman, Steven Sun, Angela Howes, Jingzhao Wang, Peng Wu, Jianyong Li
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study. Cancer medicine 7 (4) (2018)
Xuejiao Yin, Liang Tang, Fengjuan Fan, Qinyue Jiang, Chunyan Sun, Han Yan
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017. Cancer cell international 18 (2018)
Bo Tang, Aoshuang Xu, Jian Xu, Haifan Huang, Lei Chen, Yan Su, Lannan Zhang, Junying Li, Fengjuan Fan, Jun Deng, Liang Tang, Chunyan Sun, Han Yan
MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling. International journal of cancer 142 (1) (2017)

Han Yan.css-eqlu8i{font-size:small;padding-left:4px;} (Yu Hu)

Publication Activity (10 Years)

Top Topics

Top Venues

Han Yan (Yu Hu)